
Commentary|Podcasts|December 2, 2025
Breaking Down CELEBRATE and POLY-HF: Two Paths to Better Cardiac Care
Fact checked by: Ron Panarotti
Advertisement
In this solo episode, Craig Beavers breaks down new data from the CELEBRATE STEMI (NCT04825743) trial and the POLY-HF (NCT04633005) polypill study. He highlights what these findings could mean for real-world practice, from early antiplatelet strategies to improving adherence and outcomes in heart failure.
Show Notes:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Notifies Flu Vaccine Makers to Add Warning for Increased Febrile Seizure Risk in Young Children Day Following Vaccination
2
Unexpected Benefits, Unexpected Limits: The Changing Landscape of GLP-1 Research
3
AI-Powered Digital Twins Offer a New Window Into Tumor Metabolism in Brain Cancer
4
In 2026, Pharmacists Will Be Driving Change Across the Care Continuum
5














































































































































































































